Skip to main content

OSR Health, Inc.

corporate_fare Company Profile

OSR Health, Inc.

OSRHW·OTC·Industrial Applications And Services·CIK 0001840425

OSR Health, Inc. is a global healthcare holding company that identifies, leads, and supports the growth of its subsidiaries and subsidiary candidates based on innovative research. The company operates in South Korea and Switzerland, with an office in the United States. OSR Health, Inc. leverages its network of academic and industry leaders and investor network, including venture capital and private equity, in major healthcare markets globally. Subsidiary candidates are existing entities or new companies formed to acquire or license assets from industry or academia. The company attracts industry partners as co-investors or through technology licensing deals and may raise capital directly from private, strategic, or public investors. OSR Health, Inc. aims to pair teams and pharmaceutical or medical device technologies that can treat diseases and improve healthcare outcomes with financial and other resources. The company seeks to realize liquidity through the sale of its subsidiaries. OSR Health, Inc. is a data-driven company that evaluates subsidiary candidate opportunities by understanding target indications to identify new approaches and technologies. It collaborates with academic and industry leaders to integrate entrepreneurial scientists and business development and leadership teams. The company's leadership team supports subsidiaries in transforming discoveries into commercial products. OSR Health, Inc.'s collective expertise comes from industry veterans, scientists, capital market, and legal professionals. The company operates a hub-and-spoke business model with a centralized executive team partnering with subsidiary management teams to ensure program and corporate alignment.

OSR Health, Inc. (OTC:OSRHW) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 5 items for OSRHW at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for OSRHW spans 10-Q, 8-K.

Recent high-impact activity:

  • OSR Health Q3 Sales Fall 16%, Gross Margin Collapses to 7% With $1.37M Cash
  • Auditor Resigns Over Unpaid Fees as OSR Health Searches for Replacement
  • Nasdaq Panel Denies OSR Health Appeal, Orders Delisting; Plan Due by November 6
  • OSR Health Adds $15M Convertible Note Option to VXM01 License Settlement
  • OSR Health Faces Nasdaq Delisting: Hearing Set for September 29

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.91M
Net Income
-$27.06M
Diluted EPS
-$0.80
Op. Cash Flow
-$4.33M
Gross Profit
$592.9K
Operating Income
-$18.34M
Cash & Equivalents
$1.7M
Total Debt
$2.32M
Debt / Equity
0.02×
Net Margin
-9.31×
Shares Outstanding
26.6M sh
Source: 10-K · filed 2026-03-31 · accession 0001213900-26-037395

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 900 shares in OSRHW as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On November 13, 2026, 100.0% of OSRHW volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)900 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover1.00 at avg daily volume of 34,981
Daily short volume (FINRA facilities)100.0% of 700 shares on November 13, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with O →
$0.0037
52-week range · as of 2026-11-13 $0.0022 – $0.1045
Market cap
$3.51M
Volume
82.8K (3.1× avg)
3-mo avg 26.7K
From SEC filing · 2026-11-13

show_chartPrice Chart

Loading chart...

feed OSRHW - Latest Insights

OSRHW
Nov 13, 2026, 8:55 AM EST
Filing Type: 10-Q
Importance Score:
8
OSRHW
Nov 13, 2026, 8:37 AM EST
Filing Type: 8-K
Importance Score:
8
OSRHW
Oct 28, 2026, 9:30 AM EDT
Filing Type: 8-K
Importance Score:
9
OSRHW
Oct 16, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
OSRHW
Aug 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets